ChemOutsourcing
Event:
Date: September 5, 2026
Venue: USA,New Jersey - USA
We aspire to advance the frontiers of science with our partners, delivering solutions that bring innovative medicines to patients worldwide.
Science-led, execution focused
Sai Life Sciences is one of India’s fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO). We partner with pharmaceutical and biotechnology innovators to advance novel drug programs from discovery to commercial manufacturing—combining scientific rigor, operational excellence, and speed across the value chain.
Built on Experience
Years of expertise
0
+
R&D and manufacturing sites
across US, UK, and India
0
Regulatory inspection success across R&D, manufacturing sites
0
%
Scientists and professionals
0
+
Active customers across US, UK, EU & Japan
0
+
of the largest pharma companies are our customers
0
/25
of discovery portfolio constituted by integrated programs
0
%
Active NCE Commercial/ Phase III/ Pre-registration molecules
0
Support at every stage
We deliver capabilities across the drug development continuum to support your program at every stage—enabling faster progression with clarity as complexity increases.
End-to-End by Capability.
We deliver capabilities across the drug development continuum to support your program at every stage—enabling faster progression with clarity as complexity increases.
Target Validation to Your Lead Candidate
Lead identified to First-in-Human Trials
Early Phase (FTIH) to Late Phase (pivotal supplies)
Late Phase through to Validation & Filing
Life Cycle Management of Commercialized Products
Target Validation to Your Lead Candidate
Lead identified to First-in-Human Trials
Early Phase (FTIH) to Late Phase (pivotal supplies)
Late Phase through to Validation & Filing
Life Cycle Management of Commercialized Products
Discovery to Delivery for Small Molecules and Beyond
Discovery
Integrated discovery services across medicinal and synthetic chemistry, biology, DMPK, and toxicology—advancing programs from target validation to lead candidates through structured design, make, test and analyse (DMTA) cycles.
Formulations
Phase-appropriate formulation development across oral, parenteral, and specialty dosage forms—supporting timely clinical and commercial supply.
New Modalities
Specialized development and manufacturing expertise for complex modalities, including ADCs, peptides, lipids, and oligonucleotides—enabling scalable execution from early development onward.
Upcoming Events
EFMC Medicinal Chemistry Symposium
Event:
Date: September 10, 2026
Venue: Europe,Switzerland
Drug Discovery Innovation Programme
Event:
Date: September 22-23, 2026
Venue: Europe,Basel - Switzerland
Sai Life Sciences achieves EcoVadis Platinum Rating, joining the top 1% of companies assessed worldwide
Hyderabad, June 16, 2026:Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development, […]
Sai Life Sciences grows topline by 29% & doubles net profit in FY26
EBITDA up by 56%YoY; Net Profit up by 109%YoY Hyderabad, May 14, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: […]
Sai Life Sciences becomes first Indian CRDMO with a site powered by 100% renewable energy
Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development, and manufacturing organizations […]
Inside Sai Life Sciences’ Integrated R&D Campus: Accelerating Drug Development
In a recent feature published in R&D World, Sai Life Sciences’ Integrated R&D Campus in Hyderabad is showcased as a […]
Commercial-scale Photo Flow Chemistry successfully executed in Bidar
Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a […]
High-Throughput Experimentation platform goes live in Hyderabad
The High Throughput Experimentation (HTE) platform is now operational at our Integrated R&D Campus in Hyderabad, India. The system integrates […]
Global Footprint
Bidar, India
Unit 4 – API Manufacturing Facility
Unit 6 – Animal Health API Manufacturing Facility